LY 2245461

Drug Profile

LY 2245461

Alternative Names: LY2245461

Latest Information Update: 29 Mar 2012

Price : $50

At a glance

  • Originator Eli Lilly
  • Developer Chorus Group
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hot flashes

Most Recent Events

  • 28 Mar 2012 Discontinued - Phase-II for Hot flashes in Denmark (unspecified route)
  • 21 Jul 2008 Chorus Group completes a phase II trial in Hot flashes in Denmark
  • 21 Apr 2008 Phase-II clinical trials in Hot flashes in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top